Três novos derivados de 8-O-4'-neolignanas, fargesifenols A-C, juntamente com seis neolignanas conhecidas, foram isoladas de botões de flores de Magnolia fargesii. As estruturas foram elucidadas por métodos espectroscópicos, incluindo técnicas de RMN 1D e 2D. Os compostos foram também testados quanto à sua atividade anti-HIV-1 e quanto às citotoxicidades.
Introduction
The genus of Magnolia (Magnoliaceae) has traditionally been used as herb medicine in China for a long time. Especially, Xinyi (dried flower buds of Magnolia fargesii), has been used for the treatment of inflammatory-related diseases such as nasal congestion, empyema, sinusitis, and allergic rhinitis.
1,2 Previous phytochemical investigations have reported that this species contains several secondary metabolites such as lignans, [3] [4] [5] neolignans, 6, 7 sesquiterpenes, 2, 8 and essential oils, 9 which show various biological activities.
To search for more new bioactive compounds from this plant, we reexamined the flower buds of M. fargesii, which led to the isolation of three new 8-O-4'-neolignans, named fargesiphenols A-C (1-3), along with six known compounds (4) (5) (6) (7) (8) (9) . In addition, the anti-HIV-1 activities and their cytotoxicities were evaluated. Their structure elucidation and biological activities are described in this paper.
Results and Discussion
A 70% aq. acetone extract prepared from the flower buds of M. fargesii was partitioned between EtOAc and H 2 O. The EtOAc layer was subjected repeatedly to column chromatography on Si gel, Sephadex LH-20, RP-18 and preparative HPLC to afford compounds 1-9, including three new 8-O-4'-neolignans named fargesiphenols A-C (1-3), together with six known neolignans, polysyphorin (4), 10 virolin (5), 11 7S,8S-threo-4,7,9,9'-tetrahydroxy-3,3'-dimethoxy-8-O-4'-neolignan (6), 12 7S,8R-erythro-4,7,9,9'-tetrahydroxy-3,3'-dimethoxy-8-O-4'-neolignan (7), 12 13 and rhaphidecursinol A (9). 10 The structures of compounds 1-9 are shown in Figure 1 , and the 1 H and 13 C NMR data of compounds 1-3 are listed in Table 1 .
Compound 1 was obtained as pale yellow gum. Its molecular formula was determined as C 21 Vol. 23, No. 7, 2012 (1608, 1520, 1478 cm -1 ) could also be observed in its IR spectrum. The UV spectrum of 1 showed absorption maxima at 285 and 210 nm, which confirmed the existence of the aromatic functions. The The configuration of the two chiral carbons (C-7 and C-8) was considered to be threo according to the coupling constant (J 7.2 Hz) between H-7 and H-8, 15 which is distinct from that of the erythro diastereoisomers. 16, 17 The absolute configurations at C-7 and C-8 of 1 could be established on the basis of ROESY and CD spectroscopic evidence. 18 The CD spectrum of 1 gave a positive cotton effect at 237 nm, and clear ROESY correlations observed between H-7 and H-8, H-7 and H-2, H-7 and H 3 -9 ( Figure 3 ) indicated the 7S, 8S-configuration of 1, which was named fargesiphenol A. (Table 1) , the relative configurations of 2 and 3 were established as being the same as that of 1. The configuration of the two chiral carbons (C-7 and C-8) for 2 and 3 was considered to be threo according to the coupling constant (J 7.2 Hz) between H-7 and H-8, and a positive cotton effect at 237 nm for 2, and 238 nm for 3 in their CD spectrum indicated a 7S,8S-configuration. 15 Since some neolignans are reported to possess anti-HIV activities, 19 ,20 these have been tested for compounds 1-9. The cytotoxicity assay against C8166 cells (CC 50 ), and anti-HIV-1 activity were evaluated by the inhibition assay for the cytopathic effects of HIV-1 (EC 50 ), using azidothymidine (AZT) as a positive control (EC 50 = 0.034 µg mL -1 and CC 50 = 200 µg mL -1 ). 21 The results (Table 2 ) revealed significant activity for compounds 2, 6, 7, and 8, with therapeutic index (TI) values above 30. Compounds 1, 4, and 9 showed moderate activity with TI values above 10.
Some neolignans are also reported to possess cytotoxic activities, 22, 23 which led us to evaluate compounds 1-9 for their cytotoxicities. The cytotoxicity tests were performed in triplicate using a previously reported procedure. 24 In the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, the IC 50 was defined as the concentration of the tested compound resulting in a 50% 
Experimental

General experimental procedures
Optical rotations were measured with a Horiba SEPA-300 polarimeter. UV spectra were obtained using a Shimadzu UV-2401A spectrophotometer. A Tenor 27 spectrophotometer was used for scanning IR spectra with KBr pellets. CD spectra were measured on a JASCO J-810 spectropolarimeter. 1D and 2D NMR spectra were recorded on DRX-500 spectrometers with TMS as internal standard. HRESIMS was performed on an API QSTAR time-offlight spectrometer and a VG Autospec-3000 spectrometer, respectively. Preparative HPLC was performed on a Shimadzu LC-8A preparative liquid chromatograph with a ZORBAX PrepHT GF (21.2 mm × 25 cm, 7 μm) column or a Venusil MP C 18 (20 mm × 25 cm, 5 μm) column. Column chromatography was performed with Si gel (200-300 mesh, Qing-dao Marine Chemical, Inc., Qingdao, China), Lichroprep RP-18 gel (40-63 μm, Merck, Darmstadt, Germany) and MCI gel (75-150 μm, Mitsubishi Chemical Corporation, Tokyo, Japan). The fractions were monitored by TLC, and spots were visualized by heating Si gel plates sprayed with 5% H 2 SO 4 in EtOH.
Plant material
The flower buds of M. fargesii, indigenous to Nanzhao country, Henang province, were purchased from Kunming Herb Medicine Market in September 2010. A voucher specimen (YNNI-10-9-28) has been deposited in our laboratory.
Extraction and isolation
The air-dried and powdered flower buds of Magnolia fargesii (4.5 kg) were extracted four times with 70% aqueous acetone (4 × 3 L) at room temperature, filtered, and the filtrate evaporated under reduced pressure and partitioned with EtOAc (4 × 3 L). The EtOAc phase (212 g) was applied to silica gel (200-300 mesh) column chromatography, eluting with a CHCl 3 -MeOH gradient system (20:1, 9:1, 8:2, 7:3, 6:4, 5:5), to give six fractions A-F. Further separation of fraction B (35.8 g) by silica gel column chromatography, eluted with CHCl 3 -acetone (9:1-2:1), yielded mixtures B1-B6. Fraction B2 (8:2, 4.8 g) was subjected to silica gel column chromatography using petroleum ether-acetone, and semi-preparative HPLC (55% MeOH-H 2 O, flow rate 12 mL min -1 ) to give 3 (22.6 mg), 4 (18.9 mg), 5 (22.7 mg) and 9 (28.5 mg). Fraction B3 (7:3, 5.47 g) was subjected to silica gel column chromatography using CHCl 3 -acetone, and semi-preparative HPLC (48% MeOH-H 2 O, flow rate 12 mL min -1 ) to give 1 (11.6 mg) and 2 (28.9 mg). Fraction B4 (7:3, 3.28 g) was subjected to silica gel column chromatography using CHCl 3 -acetone, and semi-preparative HPLC (40% MeOH-H 2 O, flow rate 12 mL min -1 ) to give 3 (14.2 mg), 6 (22.5 mg), and 7 (18.2 mg). For a compound to be deemed effective, an IC 50 value < 100 μmol L -1 is required. Camptothecin was used as positive control. HL-60, human acute promyelocytic leukemia; Hep-G2, human hepatocellular carcinoma; KB, human oropharyngeal epidermoid carcinoma; MDA-MB-231, human breast cancer cells.
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Anti-HIV-1 assay
The cytotoxicity assay against C8166 cells (CC 50 ) was assessed using the MTT method, and anti-HIV-1 activity was evaluated by the inhibition assay for the cytopathic effects of HIV-1 (EC 50 ). 21 
Cytotoxicity assay
The cytotoxicity tests for these compounds were performed against HL-60, Hep-G2, KB, and MDA-MB-231 tumor cell lines by the MTT-assay using camptothecin as positive control. 
